Moelis & Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Moelis & Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $2.79M | Feb 27, 2015 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $273.86M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $172.95M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($40.35M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $216.10M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $495.92M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $265.71M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $114.54M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $226.78M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $164.28M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $161.09M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.38B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.18B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.56B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.20B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.07B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $914.38M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $699.07M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $598.80M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $899.55M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $817.30M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $757.93M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.08B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $751.97M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $677.87M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $542.62M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $354.81M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $347.36M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $568.44M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $441.61M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $352.14M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $444.50M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $489.07M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $479.95M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $442.83M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $404.36M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $324.95M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $211.85M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $508.60M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $412.47M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $186.42M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $206.79M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $520.21M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $202.48M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $167.81M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $261.10M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $213.19M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $318.93M | Feb 28, 2018 |